|
DOPEY2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.31750191154379E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.51289999994475E-06 |
| Normal-vs-Stage2 |
5.564000E-04 |
| Normal-vs-Stage3 |
1.65693999999439E-05 |
| Normal-vs-Stage4 |
4.12730000000083E-05 |
| Stage1-vs-Stage2 |
1.198640E-01 |
| Stage1-vs-Stage3 |
2.120400E-01 |
| Stage1-vs-Stage4 |
9.274500E-02 |
| Stage2-vs-Stage3 |
4.678000E-01 |
| Stage2-vs-Stage4 |
8.608800E-01 |
| Stage3-vs-Stage4 |
5.455400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.55007167896338E-12 |
| Normal-vs-AfricanAmerican |
2.304200E-01 |
| Normal-vs-Asian |
2.304300E-02 |
| Caucasian-vs-AfricanAmerican |
6.953700E-04 |
| Caucasian-vs-Asian |
7.395800E-01 |
| AfricanAmerican-vs-Asian |
3.459200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.82254211722466E-12 |
| Normal-vs-Female |
9.703900E-03 |
| Male-vs-Female |
3.90810000028274E-07 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.476300E-02 |
| Normal-vs-Age(41-60Yrs) |
6.95790003391039E-09 |
| Normal-vs-Age(61-80Yrs) |
1.00319999973841E-07 |
| Normal-vs-Age(81-100Yrs) |
6.009600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.670200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.439800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.738600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.480600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.832800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.111600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.428800E-01 |
| Normal-vs-Grade 2 |
2.86289999995581E-06 |
| Normal-vs-Grade 3 |
1.23010002184287E-09 |
| Normal-vs-Grade 4 |
6.998700E-04 |
| Grade 1-vs-Grade 2 |
2.246400E-02 |
| Grade 1-vs-Grade 3 |
7.017100E-04 |
| Grade 1-vs-Grade 4 |
9.503000E-03 |
| Grade 2-vs-Grade 3 |
6.723800E-02 |
| Grade 2-vs-Grade 4 |
2.086600E-01 |
| Grade 3-vs-Grade 4 |
8.154600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.95190000002099E-06 |
| Normal-vs-ccB subtype |
2.75870000177036E-08 |
| ccA subtype-vs-ccB subtype |
1.685860E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.74060000249321E-08 |
| Normal-vs-N1 |
1.556440E-02 |
| N0-vs-N1 |
1.575240E-01 |
|
|
